Fracaso del tratamiento antirretroviral y terapias de salvamento. Revisión actualizada

Díaz Torres, Héctor Manuel; Ruibal Brunet, Ignacio; Sánchez Ruiz, Julieta.
Rev. cuba. med ; 42(4)jul.-ago. 2003. tab
Artigo em Espanhol | LILACS | ID: lil-390169

Documentos relacionados

  1. Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance.
  2. Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1.
  3. Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies.
  4. Immune Responses to Retroviruses.
  5. A field guide to endogenous retrovirus regulatory networks.
  6. PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests".
  7. Structured treatment interruption for patients with human immunodeficiency virus infection.
  8. Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Preexposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073.
  9. Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
  10. Failure of pre-exposure prophylaxis with on-demand tenofovir disoproxil fumarate/emtricitabine resulting in emergence of antiretroviral resistance.